Navigation Links
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
Date:1/23/2010

Human trials soon to begin which could lead to new treatments for millions of women suffering from fibroid tumors

Nashville, TN (Vocus) January 22, 2010 -- Researchers at Meharry Medical College have discovered that an extract of green tea could be used as a treatment for uterine fibroids, a disease that affects forty percent of reproductive age women.

An article published this week in the American Journal of Obstetrics and Gynecology, by Meharry’s Director of Clinical Research, Dr. Ayman Al-Hendy and his team of investigators, stated that an extract of green tea has the ability to kill human leiomyoma cells in tissue cultures and can eradicate fibroid lesions in animal models.

Al-Hendy said if the treatment is found to be effective in humans it can change the lives of millions of women who are currently faced with hysterectomy as their only treatment option.

“If we can prove this compound is effective, millions of women can start self treatment and self management,” he said.

The symptoms of uterine fibroids are often debilitating and include excessive vaginal bleeding, anemia, fatigue and lack of energy. According to Al-Hendy, women who suffer from uterine fibroids may lose time from work, have higher medical expenses and often need advanced medical treatment in order to become pregnant – all things that cause both emotional and economic hardship for families.

Al-Hendy and his team have conducted extensive research on the treatment of fibroid tumors and are dedicated to finding a cure for this disease which disproportionately affects African-American women who are four times more likely to be affected than women from other ethnic groups.

Researchers are in the process of recruiting participants for human trials that will begin soon.

The research will be conducted under the umbrella of the Meharry Clinical and Translational Research Center (MeTRC). In 2009, Meharry was awarded a $21.4 million grant from the National Center for Research Resources (NCRR) to establish MeTRC which will help accelerate the process of turning laboratory discoveries into actual cures and treatments used by patients.

MeTRC is a “center without walls” comprised of the Center for AIDS Health Disparities Research, the Center for Women’s Health Research and the Participant and Clinical Interactions Resource. Al-Hendy and Dr. James E.K. Hildreth serve as the principal investigators of this institutional grant.

About Meharry Medical College: Meharry Medical College is the nation’s largest private, independent, historically black academic health center dedicated solely to educating minority and other health professionals. True to its heritage, it is a United Methodist Church affiliated institution. The College is particularly well known for its uniquely nurturing, highly effective educational programs; emerging preeminence in health disparities research; culturally sensitive, evidence-based health services; and significant contribution to the diversity of the nation’s health professions workforce. Diverse Issues in Higher Education’s ranking of institutions annually lists Meharry as a leading national educator of African Americans with M.D. and D.D.S. degrees, and Ph.D. degrees in the biomedical sciences. Visit www.mmc.edu to learn more.

Contact:
Janet M. Caldwell: 615.500.0632
Cynthia Yeldell: 615.327.6986 or 615.280.0319

###

Read the full story at http://www.prweb.com/releases/Meharry_Medical_College/Uterine_Fibroid_Research/prweb3499084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. Researchers discover method to objectively identify PTSD
4. Researchers find a treatment for deadly brain tumor
5. Researchers find new insights into inherited retinal disease
6. Pitt researchers raise concern over frequency of surveillance colonoscopy
7. Stress triggers tumor formation, Yale researchers find
8. Johns Hopkins researchers say vaccine appears to mop up leukemia cells Gleevec leaves behind
9. St. Johns wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say
10. Young hunters most likely to be injured using tree stands, say UAB researchers
11. Researchers find clues to why some continue to eat when full
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
(Date:12/7/2016)... ... December 07, 2016 , ... Baciocco Brothers Insurance Agency, a ... the Sacramento/Folsom region, is initiating a charity event to raise support and awareness ... Chance treatment center in Sacramento works to provide area teens and families with ...
(Date:12/7/2016)... ... ... A. Kevin Spann Insurance, a New York-based firm offering insurance and financial consultation ... drive to raise funds that will benefit the Marine Corps League. , The Marine ... Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans to generate ...
(Date:12/7/2016)... ... 2016 , ... Facial plastic surgeon, Dr. John D. Rachel of Timeless ... proceeds to two local organizations: North Chicago Animal Control and Friends and Our House ... team of authorized and trained volunteers who support rescued animals held in the City ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... -- Alopexx Oncology, LLC announced data from a Phase I ... composed of interleukin-2 and a CD20-targeting monoclonal antibody. The ... as Rituxan and maintains the activities of both the ... tumor targeting, engagement of the immune system, and induction ... study (abstract #95954) were presented at the 58 th ...
(Date:12/6/2016)... Dec. 6, 2016 Diabetes & Obesity Drug ... and obesity disease cluster is currently dominated by therapeutics ... 2 diabetes mellitus (T2DM), and the majority of the ... products, is attributable to these indications. While products indicated ... presence, there are a large number of these products ...
(Date:12/6/2016)... The pen needles market is projected to reach USD ... 2016, growing at a CAGR of 11.2% during the ... years, the pen needles market has witnessed various technological ... for safety injections in the healthcare industry. These advancements ... with an aim to reduce pain, increase comfort, and ...
Breaking Medicine Technology: